The short version
34 companies supply this market — deep enough that no single failure threatens the supply.
Market view
290 marketed package NDCs · 34 active manufacturers
Most dispensed: .68 mg/mL · Injection, Solution · #1 syringe, plastic/carton / 3 ml in 1 syringe, plastic · 2.68 mg/mL · Injection, Solution · #1 syringe, plastic/carton / 3 ml in 1 syringe, plastic · .25 mg/.5mL · Injection, Solution · #4 syringe, plastics/carton / .5 ml in 1 syringe, plastic · 1.34 mg/mL · Injection, Solution · #1 syringe, plastic/carton / 3 ml in 1 syringe, plastic
34 companies supply this market — deep enough that no single failure threatens the supply.
Every detected change for semaglutide, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
Other molecules FDA puts in GLP-1 Receptor Agonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.